NFKB1 and neoplasm: Figure 8 presents the levels of NF-κB in OVCAR-8 (Figure 8A) and SKOV-3 (Figure 8C) tumour implants, indicating no significant modulation by resveratrol compared to the control. However, at a concentration of 91.24 μg (2 mM), resveratrol significantly reduced the levels of phosphorylated NF-κB (pNF-κB) in both the OVCAR-8 (Figure 8B, p = 0.0004) and SKOV-3 (Figure 8D, p = 0.018) tumour implants. Interestingly, in SKOV-3 tumour implants, the dose of 45.65 μg (1 mM) of resveratrol significantly increased the levels of pNF-κB (Figure 8D, p = 0.007).